McKesson (MCK) closed the latest trading day at $640.66, indicating a -1.92% change from the previous session's end. This move lagged the S&P 500's daily gain of 0.49%. On the other hand, the Dow ...

Future performance should be driven by expanding its technology offerings and addressing high-growth therapeutic areas like specialty drugs. MCK is witnessing an improvement in its earnings ...

MCK’s shares have lost 2.7% in the past six ... indicating an improvement of 18.8% from the prior-year level. Prescription Technology Solutions This segment connects patients, pharmacies ...

McKesson Corporation (NYSE:MCK) offers healthcare services through U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International segments.

Valued at a market cap of $80.4 billion, McKesson Corporation (MCK) is a leading healthcare services and information technology company. The Irving, Texas-based company operates through four ...

Health care product distributor McKesson Corporation (MCK) reports big earnings gains, eye care acquisition.

It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment ...

McKesson (MCK) closed the latest trading day at $ ... On the other hand, the Dow registered a loss of 0.2%, and the technology-centric Nasdaq increased by 1.22%. The prescription drug ...